Leucine Supplementation to Promote Lean Growth in Early Life

补充亮氨酸促进生命早期的精益生长

• 批准号: 8677929
• 负责人: TERESA A DAVIS
• 金额: $ 33.63万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-20 至 2016-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8677929
• 关键词: Adult; Amino Acids; Animals; Basic Science; Body Composition; Branched-Chain Amino Acids; Cell Proliferation; Clinical; Complex; Consumption; Data; Desire for food; Diet; Eating; Family suidae; Feeds; Goals; Growth; Health; Health Food; Human; Infant; Insulin; Insulin Signaling Pathway; Intake; Knowledge; Laboratories; Lead; Leucine; Life; Low Birth Weight Infant; Metabolic; Methods; Mission; Modeling; Morbidity - disease rate; Muscle; Muscle Proteins; Neonatal; Nutrient; Nutritional; Nutritional Support; Oral; Outcome; Process; Production; Productivity; Protein Biosynthesis; Proteins; Public Health; Publishing; Regulation; Research; Role; Signal Pathway; Signal Transduction; Supplementation; Testing; Translating; Translation Initiation; Translations; United States National Institutes of Health; Weaning; Work; base; cost; dietary restriction; dietary supplements; experience; falls; feeding; improved; innovation; mTOR protein; meetings; neonate; novel; oxidation; prevent; protein degradation; protein intake; response; satellite cell

DESCRIPTION (provided by applicant): Despite improvements in the nutritional management of low birth weight infants and early weaned pigs, many experience growth faltering and this can incur both short- and long-term costs in terms of metabolic health and productivity. Our long-term goal is to identify strategies to optimize the nutritional management of both the human infant and the young pig whose growth has been compromised. The objective of this application is to determine whether the use of an oral leucine supplement can be used to enhance lean growth in early life when the intakes of protein and/or energy are marginal. The central hypothesis is that leucine supplementation stimulates the signaling pathways that regulate protein synthesis and satellite cell replication and inhibit protein degradation during early life, and these effects enhance lean growth when sustained over the long-term. The hypothesis is based on data from the applicants' laboratories. The rationale is that understanding the fundamental mechanisms by which leucine modulates lean body mass during early life has the potential to translate into practices that will improve lean growth of low birth weight infants and early weaned piglets. Guided by strong preliminary data, this hypothesis will be tested by pursuing two specific aims: 1) Determine whether prolonged leucine supplementation of a marginal protein diet enhances lean mass by up-regulating protein synthesis and myonuclear accretion and down-regulating protein degradation, and also determine whether this response requires the addition of other branched-chain amino acids; and 2) Determine if supplementation with leucine, or leucine and additional branched chain amino acids, of a diet that is marginally restricted in both protein and energy will enhance lean mass accretion, and to identify the mechanisms involved. We will determine body composition, growth rate, feed efficiency, protein synthesis and degradation rates, satellite cell abundance and proliferative capacity, amino acid signaling to translation, degradation signaling, and amino acid oxidation in young pigs fed for 10 d leucine or branched-chain amino acid supplemented diets that are marginally (80%) restricted in protein (Aim 1) or protein and energy (Aim 2). The methods are well-established in the applicants' laboratories. The approach is innovative, because it will examine the coordinated response of muscle protein synthesis, protein degradation, and myonuclear accretion to long-term leucine supplementation during early life and determine the impact on lean growth. The proposed work is unique because it is the first to comprehensively examine the coordinated regulation of all the component processes that determine muscle growth. The proposed research is significant, because it is expected to advance our understanding of the role of leucine in the regulation of lean growth in early life. The results will provide important novel information on the potential for using leucine supplementation to optimize the nutritional management of low birth weight infants, and to improve the efficiency of utilization of dietary nutrients for pork production.

描述（由申请人提供）：尽管低出生体重婴儿和早期断奶猪的营养管理有所改善，但许多猪的生长缓慢，这可能导致代谢健康和生产力方面的短期和长期成本。我们的长期目标是确定优化人类婴儿和生长受到影响的幼猪营养管理的策略。本申请的目的是确定当蛋白质和/或能量的摄入是边际的时，口服亮氨酸补充剂的使用是否可以用于在生命早期增强瘦肉生长。核心假设是，亮氨酸补充剂刺激调节蛋白质合成和卫星细胞复制的信号通路，并在生命早期抑制蛋白质降解， 并且这些效果在长期持续时增强瘦肉生长。该假设基于申请人实验室的数据。其基本原理是，了解亮氨酸在生命早期调节瘦体重的基本机制，有可能转化为改善低出生体重婴儿瘦体重生长的实践， 早期断奶仔猪在强有力的初步数据的指导下，将通过追求两个具体目标来检验这一假设：1）确定边缘蛋白质饮食的长期亮氨酸补充是否通过上调蛋白质合成和肌层增加以及下调蛋白质降解来增强瘦体重，并且还确定这种响应是否需要添加其他支链氨基酸;和2）确定在蛋白质和能量都略微受限的饮食中补充亮氨酸或亮氨酸和另外的支链氨基酸是否会增强瘦体重增加，并确定所涉及的机制。我们将确定身体组成，生长速度，饲料效率，蛋白质合成和降解率，卫星细胞丰度和增殖能力，氨基酸信号翻译，降解信号，和氨基酸氧化的幼猪饲养10天亮氨酸或支链氨基酸补充饲料，蛋白质（目标1）或蛋白质和能量（目标2）限制。这些方法在申请人的实验室中已得到充分确立。该方法是创新的，因为它将检查肌肉蛋白质合成，蛋白质降解和肌肉生长对早期生活中长期亮氨酸补充的协调反应，并确定对瘦肉生长的影响。这项研究是独一无二的，因为它是第一个全面研究决定肌肉生长的所有组成过程的协调调节的研究。这项研究意义重大，因为它有望促进我们对亮氨酸在早期生活中调节瘦肉生长的作用的理解。这些结果将为利用亮氨酸补充剂优化低出生体重儿的营养管理和提高猪肉生产中膳食营养素的利用效率提供重要的新信息。